naringenin has been researched along with Pulmonary Hypertension in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agha, AM; Ahmed, LA; Obaid, AA; Zaki, HF | 1 |
1 other study(ies) available for naringenin and Pulmonary Hypertension
| Article | Year |
|---|---|
Naringenin adds to the protective effect of L-arginine in monocrotaline-induced pulmonary hypertension in rats: favorable modulation of oxidative stress, inflammation and nitric oxide.
Topics: Animals; Anti-Inflammatory Agents; Arginine; Caspase 3; Flavanones; Hypertension, Pulmonary; Inflammation; Male; Monocrotaline; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Peroxidase; Pulmonary Artery; Rats, Wistar; Tumor Necrosis Factor-alpha | 2014 |